In the $9 billion blood glucose monitoring market, we’ve seen a sea of Web-based programs, mobile apps and devices with wireless capabilities.But here’s a new device that goes a step further. Instead of transmitting data, it analyzes data as a physician would, using proprietary software to generate recommendations on how diabetes patients should adjust their [...]
[Read more of this report]A novel targeted cancer therapy may have a place in the multibillion-dollar cancer therapeutics market if it delivers positive results in an ongoing phase 1 clinical trial and attracts enough investor interest.Using nucleic acid-based DNA-interference technology, ProNAi Therapeutics has created a class of therapies to treat cancer and other complex genetic diseases. Its most advanced [...]
[Read more of this report]Replacing the painful biopsy process with an instrument system and reagent kit that could detect cancer cells in the blood before they metastasize is the goal of a touted startup hoping to raise money this year.With its microfluidic chip to detect, separate and capture circulating cancer cells from peripheral whole blood, DeNovo Sciences hopes to [...]
[Read more of this report]AlphaCore Pharma is ready to begin a phase 1 clinical trial to evaluate the safety and tolerability of its protein therapeutic agent intended to remove cholesterol from tissues and circulating cells in patients with coronary artery disease.Conducted at the National Institutes of Health, the study will produce results by the third quarter, according to AlphaCore’s [...]
[Read more of this report]A software company making 3-D medical visualization and imaging analysis that allows technology for real-time exploration of inside the human body from any position has started off the year by raising $3.6 million.According to its website, Intrinsic Medical Imaging LLC’s technology allows for noninvasive, interactive, full freedom of motion exploration of the body from all [...]
[Read more of this report]A Midwest medical device startup is looking to raise $2 million for its computer aided diagnostic imaging technology that measures and visualizes tissue motion using ultrasound.UltraSound Medical Devices Inc., which does business under the name Epsilon Imaging, develops products with its proprietary TissueTrack technology that uses algorithms along with the natural acoustic patterns, or “speckles,” [...]
[Read more of this report]The race to substitute Medtronic’s Infuse bone growth product has a new contender in the form of a novel product made from a biomarker in the blood of black bears that allows them to hibernate for months without losing bone mass.Aursos Inc. is raising money and hoping to begin human studies in 2014 of its [...]
[Read more of this report]Cleveland Clinic spinoff Tolera Therapeutics is more than halfway to its goal of a $1.65 million round of financing for its immunomodulation therapy for organ transplant.Cofounded by Dr. Maria Siemionow, the leader of the Cleveland Clinic surgery team that performed the nation’s first near-total face transplant in 2008, Tolera is developing a drug intended to [...]
[Read more of this report]An early stage, Midwest biotech startup with a unique approach to treating damaged nervous system tissue is looking for its first round of capital.Axonia Medical has raised $1 million of the $3 million it hopes to secure in a series A financing that would carry the Kalamazoo, Michigan-based biotech through large animal trials of its [...]
[Read more of this report]Synthes is back in court, this time as the plaintiff in a lawsuit against Stryker Corp. (NYSE: SYK) accusing the Michigan-based medical device company of trying to obtain “an improper competitive advantage.”The complaint,filed in federal court in Philadelphia, also singled out three former sales staff from Synthes’ San Francisco sales unit who resigned from the [...]
[Read more of this report]